跳至主要内容
临床试验/NCT03335020
NCT03335020撤回1 期

Assessment of Contrast-enhanced Ultrasonography, Shear Wave Elastography, Strain Imaging, and 3-D Volume Ultrasonography on Arterial Wall Visualization and Stiffness in Patients With Fibromuscular Dysplasia...

Mayo Clinic1 个研究点 分布在 1 个国家开始时间: 2018年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
撤回
发起方
Mayo Clinic
试验地点
1
主要终点
Number of Subjects who Completed All of the Ultrasound Examinations

研究概览

简要总结

The researchers are trying to see whether contrast-enhanced ultrasonography, shear wave elastography, strain imaging, and 3-D volume ultrasonography improves arterial wall visualization and identifies arterial elastic properties among individuals with fibromuscular dysplasia (FMD), atherosclerosis, personal history of spontaneous coronary artery dissections (SCAD), or personal history of segmental arterial mediolysis (SAM) that may be different compared to those without the aforementioned conditions.

详细描述

Aims, purpose, or objectives:

  1. To describe whether contrast-enhanced ultrasonography, strain imaging, and 3-D volume ultrasonography are helpful to characterize affected arteries and improve the imaging of arterial wall among patients with Fibromuscular Dysplasia (FMD) and segmental arterial mediolysis (SAM).
  2. Evaluate the arterial elastic properties of individuals with FMD and compare to normal individuals, those with atherosclerosis disease, those with personal history of spontaneous coronary artery dissections (SCAD), and/or personal history of segmental arterial mediolysis (SAM) by elastography.
  3. Identification of vulnerable arterial elastic properties using contrast-enhanced ultrasonography, shear wave elastography, strain imaging, and 3-D volume ultrasonography to predict short-term and long-term outcomes among individuals with FMD, normal individuals, those with atherosclerosis disease, those with SCAD, and/or SAM.
  4. Develop risk factor profiles and risk score systems of patients undergoing contrast-enhanced ultrasonography, shear wave elastography, strain imaging, and 3-D volume ultrasonography among individuals with FMD, those with atherosclerosis disease, those with personal history of SCAD, and/or personal history of SAM.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of fibromuscular dysplasia (FMD), and/or segmental arterial mediolysis (SAM), and/or spontaneous coronary artery dissection (SCAD), and those with atherosclerosis, and normal individuals.
  • Adult male and non-pregnant female patient 18-100 years of age.
  • Patients who are able and willing to sign the informed consent will be enrolled.

排除标准

  • Missing records to determine whether or not they have fibromuscular dysplasia (FMD), and/or segmental arterial mediolysis (SAM), and/or spontaneous coronary artery dissection (SCAD), and those with atherosclerosis, and normal individuals.
  • Patients who do not accept to participate in research studies.
  • Prior contraindication to contrast agent.
  • Women who are breastfeeding or pregnant
  • Patients less than 18 yo

研究组 & 干预措施

Normal

Placebo Comparator

Healthy volunteers. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

干预措施: Shear Wave Elastography (Device)

Normal

Placebo Comparator

Healthy volunteers. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

干预措施: Pulse Wave Imaging (Device)

Normal

Placebo Comparator

Healthy volunteers. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

干预措施: Contrast-Enhanced Ultrasound (Drug)

Normal

Placebo Comparator

Healthy volunteers. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

干预措施: Strain Imaging (Other)

Normal

Placebo Comparator

Healthy volunteers. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

干预措施: 3-D Volume Ultrasound (Device)

Fibromuscular Dysplasia (FMD)

Active Comparator

Subjects with diagnosis of FMD. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

干预措施: Shear Wave Elastography (Device)

Fibromuscular Dysplasia (FMD)

Active Comparator

Subjects with diagnosis of FMD. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

干预措施: Pulse Wave Imaging (Device)

Fibromuscular Dysplasia (FMD)

Active Comparator

Subjects with diagnosis of FMD. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

干预措施: Contrast-Enhanced Ultrasound (Drug)

Fibromuscular Dysplasia (FMD)

Active Comparator

Subjects with diagnosis of FMD. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

干预措施: Strain Imaging (Other)

Fibromuscular Dysplasia (FMD)

Active Comparator

Subjects with diagnosis of FMD. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

干预措施: 3-D Volume Ultrasound (Device)

Atherosclerosis

Active Comparator

Subjects with diagnosis of atherosclerosis. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

干预措施: Shear Wave Elastography (Device)

Atherosclerosis

Active Comparator

Subjects with diagnosis of atherosclerosis. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

干预措施: Pulse Wave Imaging (Device)

Atherosclerosis

Active Comparator

Subjects with diagnosis of atherosclerosis. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

干预措施: Contrast-Enhanced Ultrasound (Drug)

Atherosclerosis

Active Comparator

Subjects with diagnosis of atherosclerosis. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

干预措施: Strain Imaging (Other)

Atherosclerosis

Active Comparator

Subjects with diagnosis of atherosclerosis. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

干预措施: 3-D Volume Ultrasound (Device)

Spontaneous Coronary Artery Dissection (SCAD)

Active Comparator

Subjects with diagnosis of SCAD. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

干预措施: Shear Wave Elastography (Device)

Spontaneous Coronary Artery Dissection (SCAD)

Active Comparator

Subjects with diagnosis of SCAD. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

干预措施: Pulse Wave Imaging (Device)

Spontaneous Coronary Artery Dissection (SCAD)

Active Comparator

Subjects with diagnosis of SCAD. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

干预措施: Contrast-Enhanced Ultrasound (Drug)

Spontaneous Coronary Artery Dissection (SCAD)

Active Comparator

Subjects with diagnosis of SCAD. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

干预措施: Strain Imaging (Other)

Spontaneous Coronary Artery Dissection (SCAD)

Active Comparator

Subjects with diagnosis of SCAD. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

干预措施: 3-D Volume Ultrasound (Device)

Segmental Arterial Mediolysis (SAM)

Active Comparator

Subjects with diagnosis of SAM. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

干预措施: Shear Wave Elastography (Device)

Segmental Arterial Mediolysis (SAM)

Active Comparator

Subjects with diagnosis of SAM. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

干预措施: Pulse Wave Imaging (Device)

Segmental Arterial Mediolysis (SAM)

Active Comparator

Subjects with diagnosis of SAM. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

干预措施: Contrast-Enhanced Ultrasound (Drug)

Segmental Arterial Mediolysis (SAM)

Active Comparator

Subjects with diagnosis of SAM. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

干预措施: Strain Imaging (Other)

Segmental Arterial Mediolysis (SAM)

Active Comparator

Subjects with diagnosis of SAM. Assessment using Shear Wave Elastography, Pulse Wave Imaging, Contrast-Enhanced Ultrasound, Strain Imaging and 3-D Volume ultrasound

干预措施: 3-D Volume Ultrasound (Device)

结局指标

主要结局

Number of Subjects who Completed All of the Ultrasound Examinations

时间窗: 2 years after starting enrollment

Completion of ultrasound examinations to determine visualization of arterial wall (contrast-enhanced ultrasound, 3-D volume ultrasound) and its mechanical properties (shear wave elastography, pulse wave imaging, strain imaging)

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

Matthew W. Urban

Associate Professor of Biomedical Engineering

Mayo Clinic

研究点 (1)

Loading locations...

相似试验